These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 9952385

  • 21. Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
    Sabin CA, Devereux HL, Clewley G, Emery VC, Phillips AN, Loveday C, Lee CA, Griffiths PD.
    J Infect Dis; 2000 May; 181(5):1800-3. PubMed ID: 10823788
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
    Justice AC, Stein DS, Fusco GP, Sherrill BH, Fusco JS, Danehower SC, Becker SL, Hansen NI, Graham NM, CHORUS Program Team.
    J Clin Epidemiol; 2004 Jan; 57(1):89-97. PubMed ID: 15019015
    [Abstract] [Full Text] [Related]

  • 25. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting.
    Sherer R.
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):92-7. PubMed ID: 9625390
    [Abstract] [Full Text] [Related]

  • 28. [Effectiveness of combined antiretroviral therapy on multiple AIDS-defining illnesses in an HIV seroconverter cohort].
    Ferreros I, Hurtado I, del Amo J, Muga R, del Romero J, García P, Alastrué I, Belda J, Guevara M, Pérez S, GEMES.
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):179-84. PubMed ID: 21333403
    [Abstract] [Full Text] [Related]

  • 29. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis.
    Wang F, So Y, Vittinghoff E, Malani H, Reingold A, Lewis E, Giordano J, Janssen R.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan 01; 8(1):75-82. PubMed ID: 8548350
    [Abstract] [Full Text] [Related]

  • 30. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.
    de Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, Rezza G, Pezzotti P.
    JAMA; 2000 Jul 12; 284(2):190-7. PubMed ID: 10889592
    [Abstract] [Full Text] [Related]

  • 31. Changes in the incidence of AIDS and in AIDS deaths: the effects of antiretroviral treatment.
    Commun Dis Rep CDR Wkly; 1997 Oct 24; 7(43):381. PubMed ID: 9357132
    [No Abstract] [Full Text] [Related]

  • 32. Hazard function estimation using B-splines.
    Rosenberg PS.
    Biometrics; 1995 Sep 24; 51(3):874-87. PubMed ID: 7548706
    [Abstract] [Full Text] [Related]

  • 33. [Can HIV/AIDS be healed with new therapies?].
    Battegay M.
    Praxis (Bern 1994); 1997 May 28; 86(22):931-2. PubMed ID: 9289789
    [No Abstract] [Full Text] [Related]

  • 34. Does drug use cause AIDS?
    Ascher MS, Sheppard HW, Winkelstein W, Vittinghoff E.
    Nature; 1993 Mar 11; 362(6416):103-4. PubMed ID: 8095697
    [Abstract] [Full Text] [Related]

  • 35. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.
    Hessol NA, Koblin BA, van Griensven GJ, Bacchetti P, Liu JY, Stevens CE, Coutinho RA, Buchbinder SP, Katz MH.
    Am J Epidemiol; 1994 Jun 01; 139(11):1077-87. PubMed ID: 8192140
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.
    Detels R, Muñoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP.
    JAMA; 1998 Nov 04; 280(17):1497-503. PubMed ID: 9809730
    [Abstract] [Full Text] [Related]

  • 37. [Socio-demographic factors associated with the progression of HIV infection and the impact of HAART in a seroconverter cohort in Madrid (1986-2009)].
    Monge S, Del Romero J, Rodríguez C, de Mendoza C, de Górgolas M, Cosín J, Dronda F, Pérez-Cecilia E, Peña JM, Santos I, Rubio R, Del Amo J, Grupo de Seroconvertores de la Comunidad de Madrid.
    Enferm Infecc Microbiol Clin; 2012 Mar 04; 30(3):117-23. PubMed ID: 22014512
    [Abstract] [Full Text] [Related]

  • 38. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.
    Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, Hernández-Aguado I, Meyer L, Porter K, del Amo J, CASCADE Collaboration.
    Am J Epidemiol; 2008 Sep 01; 168(5):532-40. PubMed ID: 18663213
    [Abstract] [Full Text] [Related]

  • 39. Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996.
    Schwarcz SK, Hsu LC, Vittinghoff E, Katz MH.
    Am J Epidemiol; 2000 Jul 15; 152(2):178-85. PubMed ID: 10909955
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.